NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
46 hedge funds and large institutions have $47.1M invested in NexImmune, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
2% less funds holding
Funds holding: 47 → 46 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
71% less capital invested
Capital invested by funds: $160M → $47.1M (-$113M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$961K |
| 2 |
Renaissance Technologies
New York
|
+$489K |
| 3 |
Morgan Stanley
New York
|
+$340K |
| 4 |
BlackRock
New York
|
+$320K |
| 5 |
State Street
Boston,
Massachusetts
|
+$318K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$5.21M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$2.29M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.5M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$393K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$181K |
NEXI Hedge Fund Activity: Q4 2021 in Review
46 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q4 2021, worth a combined $47.1M — down 71% from $160M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NEXI and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 12 added.
The largest buyer was JP Morgan Private Wealth Advisors, opening a new position worth an estimated $961K. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $5.21M sold.
- 46 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q4 2021, down from 47 in Q3 2021.
- Funds reported $47.1M of NexImmune, Inc. Common Stock stock for Q4 2021, down 71% quarter-over-quarter.
- 8 funds opened new NexImmune, Inc. Common Stock positions in Q4 2021 and 9 closed out, a net change of -1 holder.
- The largest NexImmune, Inc. Common Stock buyer in Q4 2021 was JP Morgan Private Wealth Advisors, an estimated $961K added.
- The largest NexImmune, Inc. Common Stock seller in Q4 2021 was Suvretta Capital Management, an estimated $5.21M sold.
Based on aggregated 13F filings for Q4 2021.